The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen



Status:Recruiting
Conditions:Blood Cancer, HIV / AIDS, Lymphoma, Hematology
Therapuetic Areas:Hematology, Immunology / Infectious Diseases, Oncology
Healthy:No
Age Range:18 - 120
Updated:3/15/2019
Start Date:May 21, 2001
End Date:May 2024
Contact:Dianna Howard, MD
Email:dhoward@wakehealth.edu

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The Prospective Collection, Storage and Reporting of Data on Patients

To provide the IRB approved mechanism for the prospective collection, analysis and reporting
of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem
cell transplant for a disease in which a research question is not being addressed and for
which peer reviewed, published data have demonstrated efficacy for this treatment approach.


Inclusion Criteria:

Planned standard of care dose intensive therapy and either an allogeneic or autologous bone
marrow transplant

Exclusion Criteria:

participation in any other treatment research protocol
We found this trial at
1
site
Wake Forest Baptist Health
Winston-Salem, North Carolina 27157
Principal Investigator: David Hurd, MD
Phone: 336-716-2843
?
mi
from
Winston-Salem, NC
Click here to add this to my saved trials